24HourWire

24HourWire

News from all angles

MedPage Today Center

'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment

(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarc…

Redirecting to MedPage Today in 3 seconds...

Read Now → Explore 24HourWire

Share this story with your network